Reoperation following mitral valve repair

Rakesh M. Suri, Hartzell V Schaff

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The management of mitral valve regurgitation (MR) has evolved significantly over the past 2 decades. During that time, there has been a change in the pathology and, consequently, the pathophysiology of patients referred for operative treatment. In current practice in the Western world, consequent to the decline in the frequency of postinflammatory valvopathy, most patients presenting for mitral valve (MV) surgery have degenerative valve disease. Two factors have been influential in broadening the indications for performing MV repair. First, patients are identified earlier and followed more regularly to prevent the deleterious consequences of chronic persistent MR on left ventricular (LV) size and function. Second, the outcome of surgical management has improved, and the long-term durability of primary and reoperative valve repair has been clearly established.

Original languageEnglish (US)
Title of host publicationRedo Cardiac Surgery in Adults
PublisherSpringer New York
Pages89-97
Number of pages9
ISBN (Print)9781461413264, 1461413257, 9781461413257
DOIs
StatePublished - Jun 1 2013

Fingerprint

Mitral Valve
Reoperation
Mitral Valve Insufficiency
Western World
Left Ventricular Function
Pathology
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Suri, R. M., & Schaff, H. V. (2013). Reoperation following mitral valve repair. In Redo Cardiac Surgery in Adults (pp. 89-97). Springer New York. https://doi.org/10.1007/978-1-4614-1326-4_11

Reoperation following mitral valve repair. / Suri, Rakesh M.; Schaff, Hartzell V.

Redo Cardiac Surgery in Adults. Springer New York, 2013. p. 89-97.

Research output: Chapter in Book/Report/Conference proceedingChapter

Suri, RM & Schaff, HV 2013, Reoperation following mitral valve repair. in Redo Cardiac Surgery in Adults. Springer New York, pp. 89-97. https://doi.org/10.1007/978-1-4614-1326-4_11
Suri RM, Schaff HV. Reoperation following mitral valve repair. In Redo Cardiac Surgery in Adults. Springer New York. 2013. p. 89-97 https://doi.org/10.1007/978-1-4614-1326-4_11
Suri, Rakesh M. ; Schaff, Hartzell V. / Reoperation following mitral valve repair. Redo Cardiac Surgery in Adults. Springer New York, 2013. pp. 89-97
@inbook{1415328d07ab4f16924d728c9438e5f2,
title = "Reoperation following mitral valve repair",
abstract = "The management of mitral valve regurgitation (MR) has evolved significantly over the past 2 decades. During that time, there has been a change in the pathology and, consequently, the pathophysiology of patients referred for operative treatment. In current practice in the Western world, consequent to the decline in the frequency of postinflammatory valvopathy, most patients presenting for mitral valve (MV) surgery have degenerative valve disease. Two factors have been influential in broadening the indications for performing MV repair. First, patients are identified earlier and followed more regularly to prevent the deleterious consequences of chronic persistent MR on left ventricular (LV) size and function. Second, the outcome of surgical management has improved, and the long-term durability of primary and reoperative valve repair has been clearly established.",
author = "Suri, {Rakesh M.} and Schaff, {Hartzell V}",
year = "2013",
month = "6",
day = "1",
doi = "10.1007/978-1-4614-1326-4_11",
language = "English (US)",
isbn = "9781461413264",
pages = "89--97",
booktitle = "Redo Cardiac Surgery in Adults",
publisher = "Springer New York",

}

TY - CHAP

T1 - Reoperation following mitral valve repair

AU - Suri, Rakesh M.

AU - Schaff, Hartzell V

PY - 2013/6/1

Y1 - 2013/6/1

N2 - The management of mitral valve regurgitation (MR) has evolved significantly over the past 2 decades. During that time, there has been a change in the pathology and, consequently, the pathophysiology of patients referred for operative treatment. In current practice in the Western world, consequent to the decline in the frequency of postinflammatory valvopathy, most patients presenting for mitral valve (MV) surgery have degenerative valve disease. Two factors have been influential in broadening the indications for performing MV repair. First, patients are identified earlier and followed more regularly to prevent the deleterious consequences of chronic persistent MR on left ventricular (LV) size and function. Second, the outcome of surgical management has improved, and the long-term durability of primary and reoperative valve repair has been clearly established.

AB - The management of mitral valve regurgitation (MR) has evolved significantly over the past 2 decades. During that time, there has been a change in the pathology and, consequently, the pathophysiology of patients referred for operative treatment. In current practice in the Western world, consequent to the decline in the frequency of postinflammatory valvopathy, most patients presenting for mitral valve (MV) surgery have degenerative valve disease. Two factors have been influential in broadening the indications for performing MV repair. First, patients are identified earlier and followed more regularly to prevent the deleterious consequences of chronic persistent MR on left ventricular (LV) size and function. Second, the outcome of surgical management has improved, and the long-term durability of primary and reoperative valve repair has been clearly established.

UR - http://www.scopus.com/inward/record.url?scp=84929288985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929288985&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-1326-4_11

DO - 10.1007/978-1-4614-1326-4_11

M3 - Chapter

AN - SCOPUS:84929288985

SN - 9781461413264

SN - 1461413257

SN - 9781461413257

SP - 89

EP - 97

BT - Redo Cardiac Surgery in Adults

PB - Springer New York

ER -